![Alexander Levitzki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Levitzki
Direttore/Membro del Consiglio presso
The Institute for Advanced Studies In Aging & Geriatric Medi
Profilo
Alexander Levitzki is the founder of TK-Signal Ltd. (founded in 2001) and NovoTyr Therapeutics Ltd. (founded in 2005).
He held the title of Chief Scientific Officer at TK-Signal Ltd. and Director & Chief Scientific Officer at NovoTyr Therapeutics Ltd. Dr. Levitzki is currently the Director at The Institute for Advanced Studies In Aging & Geriatric Medi, Director at Targimmune Therapeutics AG, Professor at The Hebrew University of Jerusalem (since 1977), and Member at Israel Academy of Sciences & Humanities.
He previously held the position of Director at BioCancell Therapeutics, Inc. and Director at Quinova Rx Ltd.
Posizioni attive di Alexander Levitzki
| Società | Posizione | Inizio |
|---|---|---|
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1977 |
The Institute for Advanced Studies In Aging & Geriatric Medi | Direttore/Membro del Consiglio | - |
Israel Academy of Sciences & Humanities
 Israel Academy of Sciences & Humanities Miscellaneous Commercial ServicesCommercial Services Operates as sciences and humanities academy | Corporate Officer/Principal | - |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Alexander Levitzki
| Società | Posizione | Fine |
|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology Is a biopharmaceuticals company | Direttore/Membro del Consiglio | 15/11/2009 |
TK-Signal Ltd.
 TK-Signal Ltd. Medical SpecialtiesHealth Technology Develops therapies for hematological cancer applications | Fondatore | - |
NovoTyr Therapeutics Ltd.
 NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops insulin-like growth factor receptor inhibiitors | Fondatore | - |
Quinova Rx Ltd.
 Quinova Rx Ltd. Pharmaceuticals: MajorHealth Technology Develops cannabinoid quinone scaffold for antineoplastic therapy | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
84
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Institute for Advanced Studies In Aging & Geriatric Medi | |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology Is a biopharmaceuticals company | Health Technology |
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology Develops therapies for hematological cancer applications | Health Technology |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops insulin-like growth factor receptor inhibiitors | Health Technology |
Quinova Rx Ltd.
Quinova Rx Ltd. Pharmaceuticals: MajorHealth Technology Develops cannabinoid quinone scaffold for antineoplastic therapy | Health Technology |
Israel Academy of Sciences & Humanities
Israel Academy of Sciences & Humanities Miscellaneous Commercial ServicesCommercial Services Operates as sciences and humanities academy | Commercial Services |
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Health Technology |
